RELEVIUM
Pancreatic cancer
Difficult to Diagnose
Pancreatic cancer has one of the lowest survival rates among other cancers because it is difficult to diagnose early. It is often diagnosed in later stages of the disease, once it has already metastasized.
RELEVIUM
Using digital tools to empower and improve the lives of patients with pancreatic cancer.
Improved quality of life of pancreatic cancer patients
through advanced pain and cachexia management,
nutrition, and physical activity interventions.
Unresponsive tumor
The tumors from pancreatic cancer don´t respond as well to commonly used cancer therapies as other less harmful types of cancer.
Serious comorbidities
Some of the comorbidities that exist as a result of pancreatic cancer are pain, emaciation, and jaundice, among others.
We use AI-based tools to empower patients in palliative care.
RELEVIUM
RELEVIUM is working on digital, AI-based solutions to facilitate patient-doctor communication, enabling patients to self-manage their disease.
Wearable smart tools such as a smartwatch and an innovative remote ultrasound patch are equipped with the necessary sensors needed in order to provide a stream of evidence on symptom progression. Pairing these with an AI-driven platform, pancreatic cancer patients are assisted and enabled to achieve the maximum achievable quality of life.
